|
The ECA RMM Working Group was founded on 7 June 2006 at the German Federal Agency for Sera and Vaccines by 11 representatives from the European Pharmaceutical Industry and the German Federal Agency for Sera and Vaccines, the Paul-Ehrlich-Institute (PEI).
During its inaugural meeting the working group reviewed the current situation of RMMs in Europe and defined a work plan.
One of the current issues the group identified is the lack of standardisation for the submission of RMMs.
Read more about the RMM Group, its goals and activities at
www.rapid-micro-group.org/.
|